当前位置:首页 > 医学文档 > 肿瘤学 > 正文

Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: Targeting SLC25A1 to overcome immune resistance

Chinese Journal of Cancer Research 页数: 20 2025-12-15
摘要: Objective: Lung adenocarcinoma(LUAD) is the most common subtype of lung cancer. Despite significant advances in immunotherapy, treatment responses vary substantially among individuals. Metab... ... (共20页)

开通会员,享受整站包年服务
说明: 本文档由创作者上传发布,版权归属创作者。若内容存在侵权,请点击申诉举报